NO20005450L - Imidazopyridinderivater som inhiberer magesyresekresjon - Google Patents

Imidazopyridinderivater som inhiberer magesyresekresjon

Info

Publication number
NO20005450L
NO20005450L NO20005450A NO20005450A NO20005450L NO 20005450 L NO20005450 L NO 20005450L NO 20005450 A NO20005450 A NO 20005450A NO 20005450 A NO20005450 A NO 20005450A NO 20005450 L NO20005450 L NO 20005450L
Authority
NO
Norway
Prior art keywords
gastric acid
acid secretion
imidazopyridine derivatives
inhibit gastric
inhibit
Prior art date
Application number
NO20005450A
Other languages
English (en)
Other versions
NO20005450D0 (no
NO317262B1 (no
Inventor
Kosrat Amin
Michael Dahlstroem
Peter Nordberg
Ingemar Starke
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20005450D0 publication Critical patent/NO20005450D0/no
Publication of NO20005450L publication Critical patent/NO20005450L/no
Publication of NO317262B1 publication Critical patent/NO317262B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
NO20005450A 1998-04-29 2000-10-27 Imidazopyridinderivater som inhiberer magesyresekresjon, farmasoytisk formulering som inneholder slike derivater, fremgangsmate for deres fremstilling, anvendelse derav, og mellomprodukter. NO317262B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9801526A SE9801526D0 (sv) 1998-04-29 1998-04-29 New compounds
PCT/SE1999/000663 WO1999055706A1 (en) 1998-04-29 1999-04-23 Imidazo pyridine derivatives which inhibit gastric acid secretion

Publications (3)

Publication Number Publication Date
NO20005450D0 NO20005450D0 (no) 2000-10-27
NO20005450L true NO20005450L (no) 2000-12-22
NO317262B1 NO317262B1 (no) 2004-09-27

Family

ID=20411154

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20005450A NO317262B1 (no) 1998-04-29 2000-10-27 Imidazopyridinderivater som inhiberer magesyresekresjon, farmasoytisk formulering som inneholder slike derivater, fremgangsmate for deres fremstilling, anvendelse derav, og mellomprodukter.
NO20005451A NO318203B1 (no) 1998-04-29 2000-10-27 Imidazopyridinderivater som inhiberer magesyresekresjon

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20005451A NO318203B1 (no) 1998-04-29 2000-10-27 Imidazopyridinderivater som inhiberer magesyresekresjon

Country Status (34)

Country Link
US (2) US6313137B1 (no)
EP (4) EP1491542B1 (no)
JP (2) JP3692034B2 (no)
KR (3) KR100650472B1 (no)
CN (2) CN1174980C (no)
AR (2) AR015769A1 (no)
AT (4) ATE307130T1 (no)
AU (2) AU769190B2 (no)
BR (2) BR9909996B1 (no)
CA (2) CA2329922C (no)
CZ (2) CZ292567B6 (no)
DE (4) DE69937076T2 (no)
DK (2) DK1073656T3 (no)
EE (2) EE04676B1 (no)
ES (2) ES2252975T3 (no)
HK (5) HK1033457A1 (no)
HU (2) HUP0102313A3 (no)
ID (2) ID27530A (no)
IL (4) IL139200A0 (no)
IS (2) IS5684A (no)
MY (2) MY121379A (no)
NO (2) NO317262B1 (no)
NZ (2) NZ507639A (no)
PL (2) PL343797A1 (no)
RU (2) RU2238271C2 (no)
SA (2) SA99200065B1 (no)
SE (1) SE9801526D0 (no)
SI (1) SI1073656T1 (no)
SK (2) SK14912000A3 (no)
TR (4) TR200003176T2 (no)
TW (2) TW490466B (no)
UA (2) UA66846C2 (no)
WO (2) WO1999055705A1 (no)
ZA (2) ZA200005796B (no)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
US6900324B2 (en) 2000-09-07 2005-05-31 Astrazeneca Ab Process for preparing a substituted imidazopyridine compound
SE0003186D0 (sv) * 2000-09-07 2000-09-07 Astrazeneca Ab New process
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
SE0100295D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100297D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100296D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
BR0206825A (pt) * 2001-02-13 2004-02-25 Astrazeneca Ab Formulação de dispersão sólida de liberação modificada, multiparticulada, processo para a preparação da formulação, uso da mesma, tablete, e, métodos para o tratamento de uma doença cardiovascular, e, para o tratamento de câncer
US20040082605A1 (en) * 2001-03-08 2004-04-29 Arne Eek Use
SE0102808D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab New compounds
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
SE0201940D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New combination II
SE0201939D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New combination
TWI351405B (en) 2002-09-19 2011-11-01 Schering Corp Novel imidazopyridines as cyclin dependent kinase
JP2006508142A (ja) 2002-11-19 2006-03-09 アルタナ　ファルマ　アクチエンゲゼルシャフト ８−置換イミダゾピリジン
AR043002A1 (es) * 2003-02-18 2005-07-13 Altana Pharma Ag Imidazopirazinas 6-substituidos
OA13151A (en) * 2003-02-26 2006-12-13 Sugen Inc Aminoheteroaryl compounds as protein kinase inhibitors.
DK1606261T3 (da) 2003-03-10 2010-01-18 Nycomed Gmbh Hidtil ukendt fremgangsmåde til fremstilling af roflumilast
SE525349C2 (sv) * 2003-06-23 2005-02-08 Volvo Penta Ab Utombordsdrev för båtar
SE0301905D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound I with therapeutic effect
SE0301903D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound III with therapeutic effect
SE0301904D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound II with therapeutic effect
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CN1874772A (zh) 2003-11-03 2006-12-06 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2－a]吡啶衍生物
SE0303451D0 (sv) * 2003-12-18 2003-12-18 Astrazeneca Ab New compounds
US20080033006A1 (en) * 2004-01-26 2008-02-07 Altana Pharma Ag 1,2,4-Triazolo[ 1,5-A] Pyridines as Gastric Acid Secretion Inhibitors
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EP1838309B1 (en) * 2004-12-17 2008-08-20 Pfizer, Inc. Chromane derivatives useful as acid pump antagonists
DK1861074T3 (da) 2005-03-16 2013-07-29 Takeda Gmbh Smagsmaskeret doseringsform indeholdende roflumilast
ES2470766T3 (es) * 2005-03-21 2014-06-24 Mei Pharma, Inc. Derivados de [1,2-a]piridina: preparación y aplicaciones farmacéuticas
US7666880B2 (en) 2005-03-21 2010-02-23 S*Bio Pte Ltd. Imidazo[1,2-A]pyridine derivatives: preparation and pharmaceutical applications
JP2008536817A (ja) * 2005-03-24 2008-09-11 グラクソ グループ リミテッド 胃腸疾患の処置用医薬として有用なイミダゾ（１，２−ａ）ピリジン誘導体
GB0513423D0 (en) * 2005-06-30 2005-08-03 Glaxo Group Ltd Novel compounds
AU2006323027B2 (en) * 2005-12-05 2012-08-02 Pfizer Products Inc Method of treating abnormal cell growth
ES2402419T3 (es) * 2005-12-05 2013-05-03 Pfizer Products Inc. Polimorfos de un inhibidor de C-MET/HGFR
KR20080108129A (ko) * 2006-03-17 2008-12-11 라퀄리아 파마 인코포레이티드 크로메인 유도체
JP5571380B2 (ja) 2006-07-24 2014-08-13 ルミナス バイオサイエンシズ，インコーポレイテッド オストワルド熟成を減少させた水不溶性の医薬品物質の固体ナノ粒子処方物
WO2008059373A1 (en) * 2006-11-17 2008-05-22 Raqualia Pharma Inc. Imidazo [1, 2-a] pyrazine derivatives and their use as acid pump antagonists
EP1974729A1 (en) * 2007-03-28 2008-10-01 Santhera Pharmaceuticals (Schweiz) AG Substituted imidazopyridine derivates as melanocortin- 4 receptor antagonists
CN102066396B (zh) * 2008-03-31 2014-03-12 科学与工业研究委员会 用作抗胃液分泌或抗溃疡剂的药物组合物
FI20086158A0 (fi) 2008-12-03 2008-12-03 Mikael Dahlstroem Imidatsopyridiinijohdannaiset
AU2014201644B2 (en) * 2008-12-03 2015-05-21 Cinclus Pharma Holding AB (publ) Imidazopyridine derivatives which inhibit the secretion of gastric acid
BRPI1013288A2 (pt) * 2009-07-09 2016-03-29 Raqualia Pharma Inc uso de um composto, método de composição farmacêutica para o tratamento de doenças em que a motilidade gastrointestinal anormal está envolvida, kit e embalagem comercial que compreende uma composição farmacêutica contendo o composto
BR112015030288B1 (pt) * 2013-06-25 2022-10-18 Ptc Therapeutics, Inc. Compostos e seu uso no tratamento de atrofia muscular espinhal
AU2014365823B2 (en) 2013-12-16 2019-05-02 Abs Development 1, Inc. P2X3 and/or P2X2/3 compounds and methods
MX367267B (es) * 2014-03-24 2019-08-12 Arqule Inc Proceso para preparar 3-(3-(4-(1-aminociclobutil)fenil)-5-fenil-3h -imidazo[4,5-b]piridin-2-il)piridin-2-amina.
CN106279151A (zh) * 2015-06-26 2017-01-04 江苏太瑞生诺生物医药科技有限公司 5-(2-(8-((2,6-二甲基苄基)氨基)-2,3-二甲基咪唑并[1,2-a]吡啶-6-甲酰胺基)乙氧基)-5-氧代戊酸的固体形式及其制备方法
KR101777971B1 (ko) * 2016-07-05 2017-09-12 제일약품주식회사 이미다조[1,2-a]피리딘 유도체, 이의 제조방법 및 이의 용도
KR20190057569A (ko) * 2017-11-20 2019-05-29 제일약품주식회사 7-아미노-1h-인돌-5-카르복사미드 유도체 및 이의 용도
CN111683976B (zh) 2018-02-05 2022-11-18 生物辐射实验室股份有限公司 具有阴离子交换-疏水混合模式配体的色谱树脂
MX2020010636A (es) * 2018-04-10 2020-10-28 Bayer Ag Proceso para la produccion de acidos 2,6-dialquilfenilaceticos.
RU2732297C2 (ru) * 2018-11-14 2020-09-15 Общество с ограниченной ответственностью "Гурус БиоФарм" Производные нестероидных противовоспалительных средств
EP4054537B1 (en) 2019-11-04 2023-06-07 Cinclus Pharma Holding AB (publ) Oral formulation of x842
WO2023079093A1 (en) 2021-11-05 2023-05-11 Cinclus Pharma Holding AB (publ) Polymorphs of the mesylate salt of linaprazan glurate
AU2022381536A1 (en) 2021-11-05 2024-05-02 Cinclus Pharma Holding AB (publ) Polymorphs of the hydrochloride salt of linaprazan glurate
KR102496869B1 (ko) * 2022-07-29 2023-02-07 제일약품주식회사 이미다조[1,2-a]피리딘 화합물의 신규 염, 이의 결정형 및 제조방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
DE3269604D1 (en) 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof
GB8722488D0 (en) * 1987-09-24 1987-10-28 Fujisawa Pharmaceutical Co Imidazopyridine compound

Also Published As

Publication number Publication date
DE69927803D1 (de) 2006-03-02
NO20005450D0 (no) 2000-10-27
AU4300699A (en) 1999-11-16
EP1491542A3 (en) 2005-01-05
HK1036984A1 (en) 2002-01-25
HK1036981A1 (en) 2002-01-25
WO1999055705A1 (en) 1999-11-04
CZ20003982A3 (cs) 2001-02-14
KR100595805B1 (ko) 2006-07-03
IL139297A0 (en) 2001-11-25
ZA200005796B (en) 2002-01-18
EP1073656A1 (en) 2001-02-07
DK1073656T3 (da) 2006-01-16
US6313137B1 (en) 2001-11-06
US6313136B1 (en) 2001-11-06
CA2329921A1 (en) 1999-11-04
TR200102728T2 (tr) 2002-06-21
EP1073656B1 (en) 2005-10-19
PL343797A1 (en) 2001-09-10
DE69937076T2 (de) 2008-05-29
MY121379A (en) 2006-01-28
KR20010043133A (ko) 2001-05-25
HK1033457A1 (en) 2001-08-31
HUP0102313A3 (en) 2002-10-28
DE69928792T2 (de) 2006-07-20
NO317262B1 (no) 2004-09-27
HUP0102425A3 (en) 2002-12-28
BR9909995B1 (pt) 2010-07-13
CZ292567B6 (cs) 2003-10-15
KR100595806B1 (ko) 2006-07-03
ZA200005797B (en) 2002-01-18
CN1306533A (zh) 2001-08-01
RU2238271C2 (ru) 2004-10-20
ATE372339T1 (de) 2007-09-15
ATE312101T1 (de) 2005-12-15
CA2329922A1 (en) 1999-11-04
SK285768B6 (sk) 2007-07-06
SA99200065A (ar) 2005-12-03
SI1073656T1 (sl) 2006-02-28
WO1999055706A1 (en) 1999-11-04
TWI250159B (en) 2006-03-01
AR015769A1 (es) 2001-05-16
JP2002513025A (ja) 2002-05-08
SA99200064B1 (ar) 2006-10-11
BR9909996A (pt) 2000-12-26
ATE372340T1 (de) 2007-09-15
IS5684A (is) 2000-10-25
CN1165535C (zh) 2004-09-08
HK1071139A1 (en) 2005-07-08
EE200000664A (et) 2002-04-15
UA67769C2 (uk) 2004-07-15
JP3692034B2 (ja) 2005-09-07
AR015768A1 (es) 2001-05-16
AU4300799A (en) 1999-11-16
EP1073657B1 (en) 2005-12-07
NO20005451L (no) 2000-12-27
EP1491542A2 (en) 2004-12-29
IL139297A (en) 2007-06-03
NZ507639A (en) 2004-01-30
EP1073657A1 (en) 2001-02-07
TR200003149T2 (tr) 2001-03-21
IL139200A (en) 2010-04-29
WO1999055706A9 (en) 2000-03-16
MY121389A (en) 2006-01-28
KR20050121760A (ko) 2005-12-27
CZ293977B6 (cs) 2004-09-15
EE04916B1 (et) 2007-10-15
EE200000626A (et) 2002-04-15
ES2249913T3 (es) 2006-04-01
DE69928792D1 (de) 2006-01-12
UA66846C2 (uk) 2004-06-15
IL139200A0 (en) 2001-11-25
EP1491543A1 (en) 2004-12-29
DK1073657T3 (da) 2006-03-13
AU769190B2 (en) 2004-01-22
ES2252975T3 (es) 2006-05-16
SK14922000A3 (sk) 2001-06-11
CA2329922C (en) 2006-04-11
KR20010043134A (ko) 2001-05-25
EP1491542B1 (en) 2007-09-05
EP1491543B1 (en) 2007-09-05
RU2235725C2 (ru) 2004-09-10
IS5683A (is) 2000-10-25
JP2002513024A (ja) 2002-05-08
EE04676B1 (et) 2006-08-15
SA99200065B1 (ar) 2006-11-07
DE69927803T2 (de) 2006-07-06
PL343801A1 (en) 2001-09-10
ID27530A (id) 2001-04-12
BR9909995A (pt) 2000-12-26
HK1033317A1 (en) 2001-08-24
TW490466B (en) 2002-06-11
CN1174980C (zh) 2004-11-10
DE69937077D1 (de) 2007-10-18
HUP0102425A2 (hu) 2001-11-28
ATE307130T1 (de) 2005-11-15
NO318203B1 (no) 2005-02-14
TR200003176T2 (tr) 2001-03-21
AU769108B2 (en) 2004-01-15
DE69937077T2 (de) 2008-05-29
ID26819A (id) 2001-02-15
BR9909996B1 (pt) 2010-08-24
CZ20003981A3 (cs) 2001-03-14
NO20005451D0 (no) 2000-10-27
CN1307577A (zh) 2001-08-08
DE69937076D1 (de) 2007-10-18
HUP0102313A2 (hu) 2001-12-28
SK14912000A3 (sk) 2001-06-11
NZ507638A (en) 2003-10-31
KR100650472B1 (ko) 2006-11-28
SE9801526D0 (sv) 1998-04-29
TR200102612T2 (tr) 2002-06-21
JP3883383B2 (ja) 2007-02-21
PL195000B1 (pl) 2007-07-31

Similar Documents

Publication Publication Date Title
NO20005451L (no) Imidazopyridinderivater som inhiberer magesyresekresjon
DK2253620T3 (da) Substituerede 3-cyanoquinoliner som protein-tyrosinkinase-inhibitorer
NO20021239L (no) Pteridinoner som kinase-inhibitorer
EE04016B1 (et) Ühendid maohappesekretsiooni inhibeerimiseks
DZ3377A1 (fr) Azaindoles
NO20010686L (no) Hydroksypipecolathydroksyaminsyrederivater som MMP inhibitorer
NO20005076D0 (no) (4-arylsulfonylamino)-tetrahydropyran-4- karboksylsyrehydroksamider
NO20012156D0 (no) Pyrazolopyridinderivater som selektive COX-2 inhibitorer
ATE305470T1 (de) Naphthyridinverbindungen
DK1086101T3 (da) Beta-carbolinforbindelser
ATE228995T1 (de) Aminomethylcarbonsäurederivate
AP2002002560A0 (en) Novel sulfonic acid derivatives
NO991560D0 (no) PDE IV som inhiberer 2-cyanoiminoimidazol-derivater
NO20031830L (no) Polysubstituerte imidazopyridiner som gastriske sekresjonshemmere
HK1054038A1 (en) Substituted n-benzyl-indol-3-yl gloyoxylic acid derivatives having an antitumural effect
IS5562A (is) Nýjar díhýdroxýhexanósýru afleiður
NO20016201D0 (no) Tienopyrimidiner som fosfodiesteraseinhibitorer
DK1105391T3 (da) Imidazo[1,2-a]pyridin-forbindelser som inhiberer mavesyreudskillelse, farmaceutiske præparater deraf og fremgangsmåder til deres fremstilling
NO20020485L (no) Heterocykliske forbindelser som inhiberer angiogenese
GB9925457D0 (en) Gastric acid secretion
NO996244D0 (no) Pyrrolidinkarboksylsyrederivater som endotelinantagonister
ATE252554T1 (de) Cinnamoylaminoalkyl-substituierte benzenesulfonamid-derivate
FI980053A0 (fi) Anordning foer utformande av fiberbollar av laongstraeckta fibrer som foeljer med enluftstroem
SI1073657T1 (sl) Imidazo piridinski derivati, ki inhibirajo izlocanje zelodcne kisline

Legal Events

Date Code Title Description
ERR Erratum

Free format text: IMIDAZOPYRIDINDERIVATER SOM INHIBERER MAGESYRESEKRESJON, FARMASOYTISK FORMULERING SOM INNEHOLDER SLIKE DERIVATER, FREMGANGSMATE FOR DERES FREMSTILLING, ANVENDELSE DERAV, OG MELLOMPRODUKTER

MM1K Lapsed by not paying the annual fees